Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets.
Kurozumi S, Alsaleem M, Monteiro CJ, Bhardwaj K, Joosten SEP, Fujii T, Shirabe K, Green AR, Ellis IO, Rakha EA, Mongan NP, Heery DM, Zwart W, Oesterreich S, Johnston SJ. Kurozumi S, et al. Among authors: heery dm. Breast Cancer Res. 2020 Aug 11;22(1):85. doi: 10.1186/s13058-020-01324-4. Breast Cancer Res. 2020. PMID: 32782013 Free PMC article.
Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome.
Elsheikh SE, Green AR, Rakha EA, Powe DG, Ahmed RA, Collins HM, Soria D, Garibaldi JM, Paish CE, Ammar AA, Grainge MJ, Ball GR, Abdelghany MK, Martinez-Pomares L, Heery DM, Ellis IO. Elsheikh SE, et al. Among authors: heery dm. Cancer Res. 2009 May 1;69(9):3802-9. doi: 10.1158/0008-5472.CAN-08-3907. Epub 2009 Apr 14. Cancer Res. 2009. PMID: 19366799 Free article.
Heterodimers of photoreceptor-specific nuclear receptor (PNR/NR2E3) and peroxisome proliferator-activated receptor-γ (PPARγ) are disrupted by retinal disease-associated mutations.
Fulton J, Mazumder B, Whitchurch JB, Monteiro CJ, Collins HM, Chan CM, Clemente MP, Hernandez-Quiles M, Stewart EA, Amoaku WM, Moran PM, Mongan NP, Persson JL, Ali S, Heery DM. Fulton J, et al. Among authors: heery dm. Cell Death Dis. 2017 Mar 16;8(3):e2677. doi: 10.1038/cddis.2017.98. Cell Death Dis. 2017. PMID: 28300834 Free PMC article.
FcγRIIIa receptor interacts with androgen receptor and PIP5K1α to promote growth and metastasis of prostate cancer.
Larsson PF, Karlsson R, Sarwar M, Miftakhova R, Wang T, Syed Khaja AS, Semenas J, Chen S, Hedblom A, Ali A, Ekström-Holka K, Simoulis A, Kumar A, Wingren AG, Robinson B, Nyunt Wai S, Mongan NP, Heery DM, Öhlund D, Grundström T, Ødum N, Persson JL. Larsson PF, et al. Among authors: heery dm. Mol Oncol. 2022 Jul;16(13):2496-2517. doi: 10.1002/1878-0261.13166. Epub 2022 Jan 23. Mol Oncol. 2022. PMID: 34932854 Free PMC article.
PIP5K1α is Required for Promoting Tumor Progression in Castration-Resistant Prostate Cancer.
Wang T, Sarwar M, Whitchurch JB, Collins HM, Green T, Semenas J, Ali A, Roberts CJ, Morris RD, Hubert M, Chen S, El-Schich Z, Wingren AG, Grundström T, Lundmark R, Mongan NP, Gunhaga L, Heery DM, Persson JL. Wang T, et al. Among authors: heery dm. Front Cell Dev Biol. 2022 Mar 21;10:798590. doi: 10.3389/fcell.2022.798590. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35386201 Free PMC article.
80 results